Barbara Jasiewicz

Dr. Barbara Jasiewicz

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Foot and Ankle Surgery
Verified
Journal Article
Closed access
BJBarbara Jasiewicz
Barbara Jasiewicz
JPJacek Pietraszek
Jacek Pietraszek
SDSławomir Duda
Sławomir Duda
SPSzymon Pietrzak
Szymon Pietrzak
BPBłażej Pruszczyński
Błażej Pruszczyński
AGAneta Gądek-Moszczak
Aneta Gądek-Moszczak

3 July 2019 in Medical Science Monitor
Verified
Journal Article
Open access
PDF file
BJBarbara Jasiewicz
Barbara Jasiewicz
EKEwa Klimiec
Ewa Klimiec
MMMagdalena Młotek
Magdalena Młotek
PGPiotr Guzdek
Piotr Guzdek
SDSławomir Duda
Sławomir Duda
GKGrzegorz Kołaszczyński
Grzegorz Kołaszczyński
BACKGROUND:There are many methods of dynamic analysis of foot loading, however, we still need a simple, easily applicable system for foot plantar pressure analysis. In this study we asked the question: “Can a new system for foot evaluation, the ITE...

19 March 2023 in Children
Verified
Journal Article
Open access
PDF file
BJBarbara Jasiewicz
Barbara Jasiewicz
WKWojciech Kacki
Wojciech Kacki
Abnormalities in cellular differentiation during embryo-fetal period may lead to various malformations of the spine. Caudal regression syndrome (CRS) is a group of defects with premature growth/development termination of the vertebral column. CRS can be divided into three types: sirenomelia, complete absence of the sacrum and partial absence of the sacrum. Genitourinary and gastrointestinal anomalies are common, with neurogenic bladder and bowel incontinence. Treatment of patients with CRS is complex and multidisciplinary and should be comprehensive. The most common orthopedic problems are: spinal deformity (kyphosis and scoliosis), spinopelvic instability and lower limbs deformities.

13 August 2024 in Surgical and Radiologic Anatomy
Verified
Journal Article
Open access
PDF file
KSKacper Stolarz
Kacper Stolarz
AOAleksander Osiowski
Aleksander Osiowski
MPMaciej Preinl
Maciej Preinl
MOMaksymilian Osiowski
Maksymilian Osiowski
BJBarbara Jasiewicz
Barbara Jasiewicz
DTDominik Taterra
Dominik Taterra
Purpose: There have been over 40 descriptions of the common developmental variants of the accessory ossicles of the feet. Although predominantly asymptomatic, they sometimes may be linked to painful conditions. One of the most common accessory ossicles in the foot is the accessory navicular bone (AN), located on the medial side of the foot. Our research provides a first meta-analysis on this topic that establishes its frequency by contrasting 39 studies from across the globe. Methods: Up to February 2024, PubMed and Embase databases were thoroughly searched for research on the AN. Eligible data regarding AN prevalence was extracted. This study strictly adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results: A total of 39 studies, 11,015 patients, and 36,837 feet were analyzed in our study. The pooled prevalence estimate (PPE) of AN was found to be 17.5% (95%CI: 11.5–25.7) and 12.6% (95%CI: 10.1–15.5) in patients and feet analyses, respectively. Accessory navicular occurred bilaterally in 50.0% of patients, with similar distribution in gender-based groups (21.1% of males and 22.0% of females were confirmed with AN). Accessory navicular was most prevalent in the East Asian population (38.4%) and least prevalent in North Americans (8.0%). No significant differences in AN prevalence were found when comparing different imaging modalities (X-ray and cadaver dissection). Conclusion: Accessory navicular is a common finding in imaging studies. Its prevalence depends on the population covered by the study but is not affected by the patient’s gender or the imaging modality utilized for AN assessment.

20 August 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
ARAnna Rafało-Ulińska
Anna Rafało-Ulińska
Ewa PoleszakEwa Poleszak
Ewa Poleszak
Aleksandra SzopaAleksandra Szopa
Aleksandra Szopa
ASAnna Serefko
Anna Serefko
MRMagdalena Rogowska
Magdalena Rogowska
GNGabriel Nowak
Gabriel Nowak
Zinc (Zn) was found to enhance the antidepressant efficacy of imipramine (IMI) in human depression and animal tests/models of depression. However, the underlying mechanism for this effect remains unknown. We measured the effect of intragastric (p.o.) combined administration of IMI (60 mg/kg) and Zn (40 mg Zn/kg) in the forced swim test (FST) in mice. The effect of Zn + IMI on serum, brain, and intestinal Zn concentrations; Zn transporter (ZnT, ZIP) protein levels in the intestine and ZnT in the brain; including BDNF (brain-derived neurotrophic factor) and CREB (cAMP response element-binding protein) protein levels in the brain were evaluated. Finally, the effect of IMI on Zn permeability was measured in vitro in colon epithelial Caco-2 cells. The co-administration of IMI and Zn induced antidepressant-like activity in the FST in mice compared to controls and Zn or IMI given alone. This effect correlated with increased BDNF and the ratio of pCREB/CREB protein levels in the prefrontal cortex (PFC) compared to the control group. Zn + IMI co-treatment increased Zn concentrations in the serum and brain compared to the control group. However, in serum, co-administration of IMI and Zn decreased Zn concentration compared to Zn alone treatment. Also, there was a reduction in the Zn-induced enhancement of ZnT1 protein level in the small intestine. Zn + IMI also induced an increase in the ZnT4 protein level in the PFC compared to the control group and normalized the Zn-induced decrease in the ZnT1 protein level in the hippocampus (Hp). The in vitro studies revealed enhanced Zn permeability (observed as the increased transfer of Zn through the intestinal cell membrane) after IMI treatment. Our data indicate that IMI enhances Zn transfer through the intestinal tract and influences the redistribution of Zn between the blood and brain. These mechanisms might explain the enhanced antidepressant efficacy of combined IMI/Zn treatment observed in the FST in mice.

27 November 2023 in Journal of Children's Orthopaedics
Verified
Journal Article
Open access
TPTomasz Potaczek
Tomasz Potaczek
BJBarbara Jasiewicz
Barbara Jasiewicz
Low back pain is a prevalent global musculoskeletal issue, with a lifetime prevalence ranging from 49% to 70% in adults. Traditionally associated with adults, recent field surveys indicate comparable prevalence rates in children and adolescents, challenging earlier assumptions. Non-specific low back pain, where the source cannot be identified through diagnostic imaging, accounts for about 80%–90% of cases. Studies have shown that over 80% of adolescents with low back pain exhibit no underlying pathology. The prevalence of low back pain in younger populations varies widely, influenced by study methodology, age, and pain types. Research suggests that back pain prevalence in adolescents increases with age, with a shift in attitudes considering it is not necessarily indicative of specific issues. Level of evidence: level V.